English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12500/13673 (91%)
Visitors : 2554443 Online Users : 255
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
神經及精神醫學研究中心
陳慧諴
--圖書
--專利
--會議論文/會議摘要
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
神經及精神醫學研究中心
>
陳慧諴
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
圖書
[
0
/1]
專利
[
0
/6]
會議論文/會議摘要
[
10
/10]
期刊論文
[
42
/43]
Siblings
何英剛(2006-2011)
[
38
/38]
劉玉麗
[
137
/141]
劉誠珍
[
37
/37]
周文海
[
12
/12]
林克明(2004-2009)
[
66
/69]
林彥鋒
[
38
/40]
王先逸(2005-2010)
[
5
/5]
王昀
[
61
/72]
王聲昌
[
56
/59]
羅爾維(2004-2012)
[
39
/39]
謝奉勳
[
32
/43]
陳嘉祥(2009-2013)
[
62
/64]
陳娟瑜(2004-2010)
[
91
/94]
陳為堅
[
58
/59]
陶寶綠
[
34
/36]
魏榮泰(2004-2010)
[
2
/2]
其他
[
157
/164]
廖定烈(2005-2008)
[
18
/18]
林兆東(2006-2009)
[
8
/8]
Community Statistics
近3年內發表的文件:18(30.00%)
含全文筆數:52(86.67%)
文件下載次數統計
下載大於0次:52(100.00%)
下載大於100次:45(86.54%)
檔案下載總次數:18071(0.31%)
最後更新時間: 2025-04-26 16:30
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Betaine mitigates reinstatement of ...
Betaine alleviates cue-induced rein...
Effects of sodium benzoate on behav...
Method and composition for decreasi...
Method and composition for decreasi...
Method and composition for decreasi...
Method and composition for decreasi...
用於減低K他命之致精神病狀副作用及成癮疾患的方法與組成物
付加的抗うつ剤組成物及びその使用方法
Fluvastatin, an HMG-CoA reductase i...
跳至:
(選擇年份)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-25 / 60. (共3頁)
1
2
3
>
>>
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2025-03-01
Fluvastatin, an HMG-CoA reductase inhibitor, exerts protective effect against NMDA-induced seizure by increasing the seizure threshold and modulating membrane excitability in embryonic rat cortical neuron
Brain Research. 2025 Mar 01;1850:Article number 149403.
2025-02-12
Effects of sodium benzoate on behavioral and synaptic deficits induced by subchronic ketamine exposure in mice
International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i152.
2025-02-12
Betaine alleviates cue-induced reinstatement of ketamine seeking via ampk activation in the nucleus accumbens core
International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i308-i309.
2025-02-12
Betaine mitigates reinstatement of methamphetamine- induced conditioned place preference in rats: Involvement of camkk2/Ampk signaling
International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i307-i308.
2024-06-27
Comparative assessment of the addictive potential of synthetic cathinones by zebrafish conditioned place preference (CPP) paradigm
Life. 2024 Jun 27;14(7):Article number 820.
2024-06
Calcium channel inhibitor and extracellular calcium improve aminoglycoside-induced hair cell loss in zebrafish
Archives of Toxicology. 2024 Jun;98(6):1827-1842.
2024-02-13
Focused ultrasound stimulation of infralimbic cortex attenuates reinstatement of methamphetamine-induced conditioned place preference in rats
Neurotherapeutics. 24 Feb 13;21(3):Article number e00328.
2023-12-06
Method and composition for decreasing the pschotomimetic and addictive disorder of ketamine
EP3463301/2023-12-06
2023-11-14
Extinction and reinstatement of methamphetamine-induced conditioned place preference in zebrafish
Addiction Biology. 2023 Nov 14;28(12):Article number e13351.
2023-09-03
Inhibitory perturbations of fluvastatin on afterhyperpolarization current, Erg-mediated K+ current, and hyperpolarization-activated cation current in both pituitary GH3 cells and primary embryonic mouse cortical neurons
Neuroscience. 2023 Sep 03;531:12-23.
2023-09-01
Method and composition for decreasing the pschotomimetic and addictive disorder of ketamine
IL263153/2023-09-01
2023-09
Gliptins normalize posttraumatic hippocampal neurogenesis and restore cognitive function after controlled cortical impact on sensorimotor cortex
Biomedicine and Pharmacotherapy. 2023 Sep;165:Article number 115270.
2023-07
Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice[Erratum:Biomedicine and Pharmacotherapy. 2021 Dec;144:Article number 112369.]
Biomedicine and Pharmacotherapy. 2023 Jul;163:Article number 114840.
2023-07
Hericium erinaceus mycelium reduces the motivation to self-administer ketamine in male rats
British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):1034.
2023-06-27
2-Fluorodeschloroketamine shares a similar pharmacological and behavioral profiles with ketamine in vitro and in vivo studies
British Journal of Pharmacology. 2023 Jun 27;180(Suppl. 1):1005.
2023-05-30
NMDA receptor glycine binding site modulators for prevention and treatment of ketamine use disorder
Pharmaceuticals. 2023 May 30;16(6):Article number 812.
2023-04-20
Comparisons of stress-related neuronal activation induced by restraint in adult male rat offspring with prenatal exposure to buprenorphine, methadone, or morphine
Chinese Physiological Society. 2023 Apr 20;66(2):65-72.
2023-03-21
Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
CA3025484/2023-03-21
2022-11-01
Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system
Neurophotonics. 2022 Nov 01;9(4):Article number 045003.
2022-11
Beneficial effects of atypical antipsychotics on object recognition deficits after adolescent toluene exposure in mice: involvement of 5-HT(1A) receptors
American Journal of Drug and Alcohol Abuse. 2022 Nov 2;48(6):673-683.
2022-09-24
L-4-Fluorophenylglycine produces antidepressant-like effects and enhances resilience to stress in mice
Biomedicine and Pharmacotherapy. 2022 Sep 24;155:Article number 113726.
2022-01-04
Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
US11213495/2022-01-04
2021-12
Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice
Biomedicine and Pharmacotherapy. 2021 Dec;144:Article number 112369.
2021-10-27
付加的抗うつ剤組成物及びその使用方法
JP6967532/2021-10-27
2021-08-13
N, N-dimethylglycine protects behavioral disturbances and synaptic deficits induced by repeated ketamine exposure in mice
Neuroscience. 2021 Aug 13;472:128-137.
顯示項目1-25 / 60. (共3頁)
1
2
3
>
>>
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋